Etiology, Clinical Presentation, Antibiotic and Surgical Treatment of Infective Endocarditis
A special issue of Antibiotics (ISSN 2079-6382).
Deadline for manuscript submissions: 30 November 2024 | Viewed by 143
Special Issue Editors
2. Department of Integrated Surgical and Diagnostic Sciences, University of Genoa, Genoa, Italy
Interests: cardiac surgery; infective endocarditis; cardiac reconstruction
Interests: cardiac surgery; infective endocarditis; cardiac reconstruction
Special Issues, Collections and Topics in MDPI journals
2. DISC Department, University of Genoa, Genoa, Italy
Interests: cardiac surgery; infective endocarditis; cardiac reconstruction
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Infective endocarditis (IE) is a harmful disease with a recently increasing incidence. Patients around the fifth or sixth decade of life are the ones mainly affected, but the percentage of elderly patients is increasing. Moreover, IE is one of the most severe complications in intravenous drug abusers (IVDAs), who are often young. Staphylococcus aureus is the most frequent and worrying pathogen, but enterococci is emerging in those with increasing age. New early diagnostic methods, such as PET or CT, and new technologies to detect and identify bacteria using PCR amplification and sequencing, are attracting attention. As for treatment, medical therapy alone is often not enough and surgery is frequently required. Surgical treatment may be quite challenging, and in-hospital mortality associated with IE remains high, sometimes exceeding 20%.
With this Special Issue, we encourage submissions of studies, including new perspectives on the etiology, clinical presentation, and treatment modalities of IE, a disease whose outcome appears definitely improvable.
In this Special Issue, original articles and reviews will be welcome.
I look forward to receiving your contributions.
Prof. Dr. Francesco Santini
Prof. Dr. Francesco Onorati
Dr. Antonio Salsano
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- infective endocarditis
- acute
- bacterial
- diagnosis
- treatment
- valvular heart disease
- cardiac surgery
- cardiac prosthesis
- complications
- intensive care
